Bibliography
Found 96 results
Filters: Author is Letendre, Scott L [Clear All Filters]
A concise panel of biomarkers identifies neurocognitive functioning changes in HIV-infected individuals. J Neuroimmune Pharmacol. 2013 ;8(5):1123-35.
. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort. J Acquir Immune Defic Syndr. 2013 ;62(1):36-42.
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.
CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease. J Neurovirol. 2015 ;21(5):559-67.
Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir. BMC Infect Dis. 2014 ;14:386.
. Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma. Journal of Neuroimmunology [Internet]. 2005 ;169(1-2):144-52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16182380
. Editorial commentary: Severe HIV-associated CD8+ T-cell encephalitis: is it the tip of the Iceberg?. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America [Internet]. 2013 ;57:109-11. Available from: https://www.ncbi.nlm.nih.gov/m/pubmed/23515206/?i=1&from=/23515206/related
. Efavirenz concentrations in CSF exceed IC50 for wild-type HIV. J Antimicrob Chemother. 2011 ;66(2):354-7.
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (London, England) [Internet]. 2005 ;19 Suppl 3:S72-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16251831
. Effects of human immunodeficiency virus and methamphetamine on cerebral metabolites measured with magnetic resonance spectroscopy. Journal of Neurovirology [Internet]. 2007 ;13:150-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17505983
. Efficacy and safety of two-drug regimens for treatment of HIV in the central nervous system. AIDS. 2020 ;34(13):1975-1977.
. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology [Internet]. 2004 ;56:416-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15349869
. Etravirine in CSF is highly protein bound. J Antimicrob Chemother. 2013 ;68(5):1161-8.
Frailty in medically complex individuals with chronic HIV. AIDS. 2019 ;33(10):1603-1611.
Frequency and predictors of self-reported prospective memory complaints in individuals infected with HIV. Archives of Clinical Neuropsychology: The Official Journal of the National Academy of Neuropsychologists [Internet]. 2007 ;22:187-95. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17289343
. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain: A Journal of Neurology [Internet]. 2006 ;129:1872-83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16735456
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. Journal of Virology [Internet]. 2005 ;79(3):1772-88. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15650202
Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 ;18(2):81-90.
Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Am J Med Genet B Neuropsychiatr Genet. 2017 ;174(4):413-426.
Is the glass three-quarters full or one-quarter empty?. J Infect Dis. 2006 ;194(12):1628-31.
. Global NeuroAIDS roundtable. J Neurovirol. 2013 ;19(1):1-9.
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology [Internet]. 2005 ;64(8):1343-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15851720
. Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid. J Neurovirol. 2022 ;28(2):281-290.
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 ;433(2):498-505.
HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 ;30(17):2591-2597.